Lanreotide Acetate for Injection
Indication
1. Active acromegaly, including patients whose serum GH level does not reach normal level after surgery for pituitary GH tumors, and after external pituitary irradiation radiotherapy. 2. Patients whose serum GH level is still elevated before the full therapeutic effect is achieved, and before surgery for pituitary tumors in some cases. 3. Severe diarrhea, flushing, electrolyte imbalance, exudative polymorphic rash caused by gastrointestinal neuroendocrine tumors and carcinoid syndrome, and AIDS-related diarrhea.
Packaging Specification
40 mg